Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 10

Results For "biomedical"

105 News Found

Novartis announces next-generation CAR-T platform, T Charge
Biotech | December 14, 2021

Novartis announces next-generation CAR-T platform, T Charge

T-Charge, a next-generation platform that aims to revolutionize CAR-T cell therapy, will serve as the foundation for various investigational CAR-T therapies


Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline
Biotech | November 26, 2021

Sanofi invests US $ 180 mn in Owkin’s AI for oncology pipeline

Owkin builds best-in-class predictive biomedical AI models and robust data sets


ADB approves US $ 1.5 bn for Covid-19 vaccines in India
News | November 25, 2021

ADB approves US $ 1.5 bn for Covid-19 vaccines in India

The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people


AstraZeneca opens Discovery Centre in Cambridge
Biotech | November 23, 2021

AstraZeneca opens Discovery Centre in Cambridge

State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem


Funding push to pharma R&D critical for unleashing next phase of growth
News | November 20, 2021

Funding push to pharma R&D critical for unleashing next phase of growth

The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation


US govt places additional order of 1.4 million courses of molnupiravir
News | November 10, 2021

US govt places additional order of 1.4 million courses of molnupiravir

Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults


Clarivate and BARDA collaborate to identify therapeutics that can be repurposed for medical countermeasures
Biotech | November 09, 2021

Clarivate and BARDA collaborate to identify therapeutics that can be repurposed for medical countermeasures

Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries


Resilience and Harvard announce five-year R&D alliance
News | October 18, 2021

Resilience and Harvard announce five-year R&D alliance

First anticipated spinout from the alliance, Circle Therapeutics, to develop novel muscle stem cell therapies for a variety of skeletal muscle disorders


Lifebit Biotech raises US $ 60 m in Series B funding
Startup | September 30, 2021

Lifebit Biotech raises US $ 60 m in Series B funding

Lifebit's accompanying suite of AI-powered end-to-end software solutions provide faster data insights, accelerate drug discovery pipelines, and improve clinical trials success


Novartis’ Kisqali data indicates longest median survival in advanced breast cancer
Drug Approval | September 20, 2021

Novartis’ Kisqali data indicates longest median survival in advanced breast cancer

With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting